Life Sciences Leaders @ NLSDays

Emmanuel Lignier, Cytiva CEO, shares his commitment to Nordic life sciences and entrepreneurs.

NLSDays – NLSInvest 2021: What are international investors are looking for? (Red Alpine & TVM Capital)

NLSInvest 2021: What’s in it for Nordic Life Science companies? (Mode Sensors, Sartar & Hemispherian)

NLSInvest – NLSDays: Why returning on a regular basis? (Gedea Biotech)

Gianfranco Grompone, BioGaia CSO about NLSDays’ Microbiome super session

Sarah Lidé, Senior Strategy Project Manager MVA about NLSDays’ Microbiome super session

NLSDays – NLSInvest 2021: What are international investors are looking for? (Graybella Capital,  IPF Partners & Illumina Ventures)

NLSInvest 2021: What’s in it for Nordic Life Science companies? (Ciana Therapeutics & Epiendo Pharmaceuticals)

NLSDays – NLSInvest 2021: What are international investors are looking for? (Asabys & Bootstrap)

NLSInvest 2021: What’s in it for Nordic Life Science companies? (2N Pharma)

Abdel Halim, President, Biomakers and Diagnostics Consulting about NLSDays’ Precision Medicine Super Session

Karin Conde-Knape, Senior Vice President, Global Drug Discovery, Novo Nordisk Consulting about NLSDays’ Precision Medicine Super Session

Sam Oddson, CMO & Co-founder, SidekickHealth about NLSDays’ The new cross-industry playground Super Session

Jessica Shull, Industry Relations, Digital Therapeutics Alliance about NLSDays’ The new cross-industry playground super session

NLSDays – NLSInvest 2021: What are international investors are looking for? (Abbvie, M Ventures)